Santhera Pharmaceuticals Holding AG Revenue and Competitors
Employee Data
Santhera Pharmaceuticals Holding AG's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CEO Assistant / Board Management Support | Reveal Email/Phone |
3 | Chief Financial Officer | Reveal Email/Phone |
4 | Chief Technology Officer | Reveal Email/Phone |
5 | Chief Medical Officer | Reveal Email/Phone |
6 | Chief Financial Officer | Reveal Email/Phone |
7 | Chief Staff | Reveal Email/Phone |
8 | Head Marketing and Field Operations | Reveal Email/Phone |
9 | Head Global HR | Reveal Email/Phone |
10 | Head Global Patient Advocacy | Reveal Email/Phone |
Santhera Pharmaceuticals Holding AG Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $28.7M | 143 | 23% | N/A | N/A |
#2 | $14.3M | 71 | 22% | N/A | N/A |
#3 | $24.5M | 122 | 42% | N/A | N/A |
#4 | $18.9M | 94 | 34% | N/A | N/A |
#5 | $25.1M | 125 | 76% | N/A | N/A |
#6 | N/A | N/A | N/A | N/A | |
#7 | $3.6M | 18 | 20% | $32.3M | N/A |
What Is Santhera Pharmaceuticals Holding AG?
Santhera Pharmaceuticals Holding AG (Santhera) is a Switzerland-based company engaged in the pharmaceutical sector. The Company is involved in the research, development and commercialization of pharmaceutical products for the treatment of neuromuscular and mitochondrial diseases. The Company's products include Catena and Raxone brands, which are primarily implemented in the symptomatic treatment of Leber's Hereditary Optic Neuropathy (LHON) diseases. Sathera Pharmaceuticals Holding AG operates through its wholly owned subsidiaries: Santhera Pharmaceuticals (Schweiz) AG, Liestal, Santhera Pharmaceuticals (USA) Inc, Santhera Pharmaceuticals (Canada) Inc, Santhera Pharmaceutical (Deutschland) GmbH and Oy Santhera Pharmaceuticals (Finland) Ltd.
keywords:N/A
N/A
Total Funding
N/A
Number of Employees
N/A
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator